Is an innovative product used primary in Europe and currently little is know about it in North America. For this reason Mexico has been chosen as the lauching platform for the United States and all of Latin America.

Our scientists have developed a formula derived from the combination of somatropin and urofollitropin, because of its effects and benefits it largely out weighs any other hormone on a worldwide scale.

Is a polypeptide hormone with a DNA origin recombinant and follicle stimulant which is produced in a natural state by the pituitary gland. The amino acid sequence of the producy is identical to the growth hormone (a hormone with a pituitary origin).

Follitropin Somatro is administered via a subcutaneous method and is the recommended form for patients with a déficit in the secretion of the growth hormone, pituitary dwarfism and in children with a low increase in height caused by Turner syndrome. Also for women who have a low amount of the stimulating follicle and an excessively high amount of the luteinizing hormone.